| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |